Related Experiment Video

Updated: Aug 5, 2026

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

Polymyalgia rheumatica in a defined elderly community

A J Silman, H L Currey

    Rheumatology and Rehabilitation
    |November 1, 1982
    PubMed

    Insights

    Screening elderly individuals using symptom questionnaires and erythrocyte sedimentation rate (ESR) tests identified polymyalgia rheumatica (PMR). This study found a higher prevalence of PMR in community-dwelling seniors than previously estimated.

    Area of Science:

    • Rheumatology
    • Geriatrics
    • Epidemiology

    Background:

    • Polymyalgia rheumatica (PMR) is an inflammatory condition primarily affecting older adults.
    • Accurate prevalence data for PMR in community-dwelling elderly populations is limited.
    • Early diagnosis and management of PMR are crucial for patient outcomes.

    Purpose of the Study:

    • To determine the prevalence of polymyalgia rheumatica (PMR) in elderly individuals receiving social services.
    • To evaluate the effectiveness of a combined symptom questionnaire and erythrocyte sedimentation rate (ESR) screening approach for PMR.

    Main Methods:

    • A screening study was conducted on 247 elderly individuals accessing social services.
    • Participants completed a symptom questionnaire relevant to PMR.
    • Erythrocyte sedimentation rate (ESR) levels were measured for all participants.

    Main Results:

    • Three cases of polymyalgia rheumatica (PMR) were identified among the 247 participants.
    • Two of the three diagnosed PMR cases were previously undiagnosed.
    • The calculated prevalence of PMR in this cohort was higher than estimates from hospital-based studies.

    Conclusions:

    • Combined symptom questionnaires and ESR estimations can effectively screen for polymyalgia rheumatica (PMR) in community settings.
    • The prevalence of PMR may be underestimated in the general elderly population.
    • Targeted screening in social services populations can uncover undiagnosed cases of PMR.

    More Related Videos

    Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain04:50

    Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

    Published on: May 16, 2025

    Therapeutic Massage for Psychological Well-being in Geriatric Oncology03:59

    Therapeutic Massage for Psychological Well-being in Geriatric Oncology

    Published on: May 22, 2026

    Related Concept Videos

    Rheumatic Heart Disease I: Introduction01:23

    Rheumatic Heart Disease I: Introduction

    Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

    The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
    Rheumatic Heart Disease III: Medical Management01:21

    Rheumatic Heart Disease III: Medical Management

    Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
    Rheumatic Heart Disease IV: Nursing Management01:20

    Rheumatic Heart Disease IV: Nursing Management

    AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
    Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

    Cardiomyopathy IV: Restrictive Cardiomyopathy

    Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...